55 related articles for article (PubMed ID: 2984580)
1. Neurobehavioural evaluation of resveratrol in murine models of anxiety and schizophrenia.
Magaji MG; Iniaghe LO; Abolarin M; Abdullahi OI; Magaji RA
Metab Brain Dis; 2017 Apr; 32(2):437-442. PubMed ID: 27878417
[TBL] [Abstract][Full Text] [Related]
2. The benzodiazepine receptor antagonists flumazenil and CGS8216 block the enhancement of fear conditioning and interference with escape behavior produced by inescapable shock.
Maier SF; Grahn RE; Maswood S; Watkins LR
Psychopharmacology (Berl); 1995 Sep; 121(2):250-8. PubMed ID: 8545531
[TBL] [Abstract][Full Text] [Related]
3. "Anxiolytic" and "anxiogenic" benzodiazepines and beta-carbolines: effects on aggressive and social behavior in rats and squirrel monkeys.
Weerts EM; Tornatzky W; Miczek KA
Psychopharmacology (Berl); 1993; 110(4):451-9. PubMed ID: 7870916
[TBL] [Abstract][Full Text] [Related]
4. Nitrous oxide anxiolytic effect in mice in the elevated plus maze: mediation by benzodiazepine receptors.
Emmanouil DE; Johnson CH; Quock RM
Psychopharmacology (Berl); 1994 Jun; 115(1-2):167-72. PubMed ID: 7862891
[TBL] [Abstract][Full Text] [Related]
5. The peripheral benzodiazepine receptor ligand Ro 5-4864 induces supraspinal convulsions in rabbits. Reversal by the central benzodiazepine antagonist Ro 15-1788.
Massotti M; Lucantoni D
Psychopharmacology (Berl); 1986; 88(3):336-40. PubMed ID: 3008210
[TBL] [Abstract][Full Text] [Related]
6. Benzodiazepine receptor mediation of behavioral effects of nitrous oxide in mice.
Quock RM; Emmanouil DE; Vaughn LK; Pruhs RJ
Psychopharmacology (Berl); 1992; 107(2-3):310-4. PubMed ID: 1319602
[TBL] [Abstract][Full Text] [Related]
7. Multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations.
Pellow S; File SE
Psychopharmacology (Berl); 1984; 83(4):304-15. PubMed ID: 6093178
[TBL] [Abstract][Full Text] [Related]
8. The anxiogenic action of RO 5-4864 in the social interaction test: effect of chlordiazepoxide, RO 15-1788 and CGS 8216.
File SE; Pellow S
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):225-8. PubMed ID: 2984580
[TBL] [Abstract][Full Text] [Related]
9. The anxiogenic action of FG 7142 in the social interaction test is reversed by chlordiazepoxide and Ro 15-1788 but not by CGS 8216.
File SE; Pellow S
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):198-205. PubMed ID: 6439138
[TBL] [Abstract][Full Text] [Related]
10. Chlordiazepoxide enhances the anxiogenic action of CGS 8216 in the social interaction test: evidence for benzodiazepine withdrawal?
File SE; Pellow S
Pharmacol Biochem Behav; 1985 Jul; 23(1):33-6. PubMed ID: 3929278
[TBL] [Abstract][Full Text] [Related]
11. Behavioural actions of Ro 5-4864: a peripheral-type benzodiazepine?
Pellow S; File SE
Life Sci; 1984 Jul; 35(3):229-40. PubMed ID: 6087055
[TBL] [Abstract][Full Text] [Related]
12. The anxiogenic action of Ro 15-1788 is reversed by chronic, but not by acute, treatment with chlordiazepoxide.
File SE; Pellow S
Brain Res; 1984 Sep; 310(1):154-6. PubMed ID: 6434155
[TBL] [Abstract][Full Text] [Related]
13. A behavioral examination of convulsant benzodiazepine and GABA antagonist, Ro 5-3663, and benzodiazepine-receptor antagonist Ro 15-1788.
Feldon J; Lerner T; Levin D; Myslobodsky M
Pharmacol Biochem Behav; 1983 Jul; 19(1):39-41. PubMed ID: 6413985
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
